Veterinary Medicine Information website

Clindaseptin 150 mg capsules for dogs

Not authorised
  • Clindamycin hydrochloride
Download as PDF

Product identification

Medicine name:
Clindaseptin 150 mg capsules for dogs
Active substance:
  • Clindamycin hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Clindamycin hydrochloride
    162.85
    milligram(s)
    /
    1.00
    Capsule
Pharmaceutical form:
  • Capsule, hard
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF01
Legal status of supply:
  • Medicinal product on medical prescription for non-renewable delivery
Authorisation status:
  • Revoked
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 835572
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0112/006

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
German (PDF)
Published on: 25/03/2019
Updated on: 13/06/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 25/03/2019
Updated on: 13/06/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 25/03/2019
Updated on: 13/06/2023
Download